Tradewinds Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Tradewinds Capital Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-119	Closed	-$1.74K	–	735
2025 Q3	$1.74K	Buy	+119	New	+$1.77K	﹤0.01%	532
2022 Q2	–	Sell	-70	Closed	-$1K	–	753
2022 Q1	$1K	Hold	70	–	–	﹤0.01%	748
2021 Q4	$1K	Hold	70	–	–	﹤0.01%	747
2021 Q3	$1K	Sell	70 -70	-50%	-$1.18K	﹤0.01%	730
2021 Q2	$2K	Hold	140	–	–	﹤0.01%	682
2021 Q1	$3K	Hold	140	–	–	﹤0.01%	615
2020 Q4	$3K	Hold	140	–	–	﹤0.01%	578
2020 Q3	$2K	Sell	140 -50	-26%	-$910	﹤0.01%	590
2020 Q2	$3K	Hold	190	–	–	﹤0.01%	543
2020 Q1	$3K	Hold	190	–	–	﹤0.01%	517
2019 Q4	$4K	Hold	190	–	–	﹤0.01%	534
2019 Q3	$3K	Hold	190	–	–	﹤0.01%	500
2019 Q2	$3K	Sell	190 -60	-24%	-$1.09K	﹤0.01%	499
2019 Q1	$5K	Buy	+250	New	+$5.03K	﹤0.01%	468

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Tradewinds Capital Management's TAK Position: Q4 2025 in Review

Tradewinds Capital Management sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 119 shares — an estimated $1.74K sold.

Tradewinds Capital Management first reported a position in TAK in Q1 2019 and held it in 14 quarters. The position peaked at $5K in Q1 2019. 349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

Tradewinds Capital Management reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
Tradewinds Capital Management sold 119 Takeda Pharmaceutical shares in Q4 2025, an estimated $1.74K.
Tradewinds Capital Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 14 quarters.
Tradewinds Capital Management's Takeda Pharmaceutical position peaked at $5K in Q1 2019.
349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Tradewinds Capital Management's 13F filing for Q4 2025, filed 14 Jan 2026.